CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 1,066 enrolled
Drug / intervention
iDAScore®device
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT04969822
NCT04969822N/ACompleted

Will Embryo Selection Through Use of Artificial Intelligence (iDA) Perform Equally Compared to Day 5 Morphology?

Vitrolife·interventional·Posted Jul 21, 2021·Updated Dec 2, 2024

In Brief

A clinical study evaluating iDAScore® for IVF and Infertility. Completed, enrolled 1,066 participants across 14 sites in 4 countries.

Detailed Summary

A non-inferiority, prospective parallel group, multi-center, randomized controlled trial to investigate whether selection of a single blastocyst for transfer using the deep learning tool, iDA, results in non-inferior clinical pregnancy rate compared to trained embryologists using standard morphology criteria.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsIVF, Infertility
CountriesAustralia, Denmark, Sweden, United Kingdom
Collaborators--

Timeline

N/ACompletedFinished
2020202120222023202420252026
First PostedJul 21, 2021
Enrollment StartFeb 20, 2020
Primary CompletionJan 24, 2023
Study CompletionNov 1, 2023
TodayJul 2, 2026
Enrollment to primary: 2.9 yearsPosted 4.9 years ago

Interventions

iDAScore®device

A system that studies time lapse images obtained from the embryo culture system, Embryoscope, throughout the development to blastocyst. The system uses data acquired from a sequence of embryo images and has taught itself to identify the embryos with the highest likelihood of implanting and leading to fetal heart-beat detection.